Improve balance through virtual reality
- Trial ID
- NCT07359716
- Official Title
- Virtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients
- Goal
- Improve balance through virtual reality
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Montiha Azeem
- Study Type
- INTERVENTIONAL
- Enrollment
- 62 participants
- Conditions
- Parkinson s Disease
- Interventions
- Conventional Physical Therapy, Virtual Reality-Based Physical Therapy
Summary For Families
The trial is testing whether virtual reality physical therapy can improve balance, gait and everyday mobility in people with Parkinson's better than conventional physical therapy, with the goal of reducing falls and making walking and balance easier. The VR sessions use simulated environments and real-time visual feedback to guide balance and gait exercises and track progress, while the conventional arm uses standard strength, balance and walking training; VR is meant to boost engagement and deliver precise movement cues that complement usual medications like levodopa. Eligible participants are men and women aged 45 to 65 with Parkinson's and good cognition, MMSE 24 or higher; people with other neurologic diseases, recent lower limb fractures, recent major peripheral surgery or trauma, or spinal cord injury are excluded.
Locations
- Shadman Medical Center, Lahore, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Conventional Physical Therapy. The trial is testing whether virtual reality physical therapy can improve balance, gait and everyday mobility in people with Parkinson's better than conventional physical therapy, with the goal of reducing falls and making walking and balance easier. The VR sessions use simulated environments and real-time visual feedback to guide balance and gait exercises and track progress, while the conventional arm uses standard strength, balance and walking training; VR is meant to boost engagement and deliver precise movement cues that complement usual medications like levodopa. Eligible participants are men and women aged 45 to 65 with Parkinson's and good cognition, MMSE 24 or higher; people with other neurologic diseases, recent lower limb fractures, recent major peripheral surgery or trauma, or spinal cord injury are excluded.
- Who can participate?
- Participants must be between 45 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.